CN1184634A - Omega -3 capsule and method for preparing same - Google Patents
Omega -3 capsule and method for preparing same Download PDFInfo
- Publication number
- CN1184634A CN1184634A CN96116616A CN96116616A CN1184634A CN 1184634 A CN1184634 A CN 1184634A CN 96116616 A CN96116616 A CN 96116616A CN 96116616 A CN96116616 A CN 96116616A CN 1184634 A CN1184634 A CN 1184634A
- Authority
- CN
- China
- Prior art keywords
- weight
- capsule
- omega
- linoleic acid
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 15
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 229960004232 linoleic acid Drugs 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 239000005060 rubber Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000007903 gelatin capsule Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 2
- 210000004556 brain Anatomy 0.000 abstract description 2
- 229960004488 linolenic acid Drugs 0.000 abstract description 2
- 210000001525 retina Anatomy 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000020778 linoleic acid Nutrition 0.000 description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 6
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- -1 ethanolamine phospholipid Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
In the encapsulating mateirial of the said capsule there are 99% of perillaseed oil containing 60-78% weight of alpha-linolenic acid and 1% weight of VE. Said product is an indis pensable substance for the development of brain and retina and the perfect function of human body. It contains no any hormone, has no any fishy smell and side effect, and possesses of obvious actions for curing and preventing cardiovascular disease and lowering the blood lipoid.
Description
The present invention relates to a kind of unsaturated fatty acid capsule and preparation method thereof, be specifically related to linoleic acid (omega-3) capsule and preparation method thereof.
Have three big serial unsaturated fatty acids in the food: oleic acid (omega-9), linoleic acid (omega-6) and linoleic acid (omega-3) be, they can not be changed mutually during metabolism in vivo, and have special physiological properties.Linoleic acid (omega-3) and metabolite thereof optionally mix some organ of homoiothermic animal, in the ethanolamine phospholipid and lipid sphyngomyelin as cerebral cortex, retina, testis and sperm, so linoleic acid (omega-3) has material impact to animal and human's body health, effectively the blood fat reducing level, weaken hematoblastic agglutination, the generation that helps to prevent and treat atherosclerosis and reduce ischemic cardiovascular and cerebral vascular disease, and show brain, sense organ and genitals's specific performance.For example by investigating, living in the arctic makes a living with hunting, based on fish and carnivorous Eskimos, although the fat mass of being eaten (accounting for total amount of heat about 40%), cholesterol (about 800 mg/day) and total amount of heat (every day 3, more than 000 card), and coronary heart disease, cancer, the M ﹠ M of diseases such as diabetes but is significantly less than (having only about 1/10) other crowds, also be significantly less than and migrate other geographic Eskimos, once the Ace Ji Mo family in the Canada and the U.S. was investigated, although their grand parents, father and mother almost do not have myopic, but in their following generation (young about 20 years old), have 60%-88% that myopia has taken place unexpectedly, through a series of investigation and research, found answer finally: be that the omega-3 that the fish of the arctic is rich in has played pivotal role.Omega-3 receives the very big concern of medical circle at this point.
Linoleic acid (omega-3) is except being present in salmon, morrhua, tuna and the Antarctic krill, also be present in the phospholipid of plant chlorophyll, in vegetable oil, contain 7-12% in walnut oil, soybean oil and the Oleum Brassicae campestris approximately, contain about 50% in the Semen Lini oil, and Fructus Perillae oil content is up to 60-70%.Fish oil is owing to be rich in eicosapentaenoic acid (EPA) and docosahexenoic acid (DHA), very easily oxidation, in processing and preservation process, easily produce the peroxide that is harmful to human body, in addition-aspect, DHA is the active function form of omega-3, and linoleic acid (LN) and EPA only just are converted into DHA when human body needs, and the animality omega-3 of human body excess intake can cause the effect of paying that DHA is excessive and produce, too low as blood viscosity, symptoms such as epistaxis.Because animal body contains material such as cholesterol and EPA, DHA are not easily separated, so the omega-3 of animal origin has materials such as cholesterol.
For this reason, the object of the present invention is to provide a kind of capsule and preparation method thereof of the omega-3 of producing by the plant Fructus Perillae.
Above-mentioned purpose of the present invention realizes in the following manner: a kind of omega-3 capsule is characterized in that containing in the capsule α-linoleic acid that contains 60-70% that extracts from the Folium Perillae seed of 99 parts of weight and the vitamin E of 1 part of weight.
The content that it is characterized in that every capsules is 250mg.
A kind of preparation method of omega-3 capsule, it is characterized in that (content the is 60-70%) Fructus Perillae oil of α-linoleic acid of 99% weight that will extract from the Folium Perillae seed and the vitamin E of 1% weight stir mixing channel after, it is standby in the storage tank to pack into, it is standby in addition the ethyl hydroxybenzoate of the glycerol of the gelatin of 1 part of weight, 0.3 part of weight, 0.0015 part of weight and an amount of distilled water mix homogeneously to be made the rubber storage tank of packing into, and above-mentioned α-linoleic acid and vitamin E and rubber are made the soft gelatin capsule that every ball is 250mg by the drop pill machine.
Advantage of the present invention is tangible, though Fructus Perillae oil is than the poor stability of Oleum Glycines, Oleum Brassicae campestris, than fish oil good stability, add vitamin E especially in the present invention after, in processing, in storage and the use, be difficult for producing peroxide, in addition, increase under the effect of enzyme at desaturase and carbochain, according to the human body needs, ability is converted into DHA by EPA after α-linoleic acid is converted into EPA again, does not therefore have the problem that has side effects because of DHA is excessive.Do not contain cholesterol in the plant, oil is pure, and abnormal smells from the patient delicate fragrance is agreeable to the taste, has overcome fish oil and has contained the shortcoming that has a fish like smell.Folium Perillae seed low price, the source is abundant, and is easy to process, for reducing cost, improves the quality of omega-3, opened up new approach.Below, will be in conjunction with specific embodiments, the present invention is described in further detail.
Embodiment:
(1) getting the Folium Perillae seed immerses in 60 ℃ of warm water and soaks, drain after removing impurity, adopt the batch (-type) milling process, squeeze Fructus Perillae oil, the vitamin E that in the Fructus Perillae oil that obtains, adds 1% weight, by the ultrafilter membrane of aperture 0.3 μ, obtain the Fructus Perillae oil of the alpha-linolenic acid oil of the clarifying 60-70% of containing (weight) after stirring, it is standby to put into storage tank.
(2) in another storage tank, get the gelatin of 1 part of weight, the glycerol of 0.3 part of weight, the ethyl hydroxybenzoate of 0.0015 part of weight and an amount of distilled water are made rubber behind the mixing, and it is standby to put into storage tank.
(3) (1) and (2) is made the soft gelatin capsule that every ball is 250mg by the drop pill machine.
More than, embodiment except the Folium Perillae seed, also can adopt Semen Lini to use the same method and produce soft gelatin capsule of the present invention only for illustrative purposes.
Claims (4)
1. omega-3 capsule is characterized in that containing in the capsule Fructus Perillae oil of the α-linoleic acid that contains 60-70% weight that extracts from the Folium Perillae seed of 99 parts of weight and the vitamin E of 1 part of weight.
2. capsule as claimed in claim 1, the content that it is characterized in that every capsules is 250mg.
3. the preparation method of an omega-3 capsule, it is standby the storage tank to pack into after the vitamin E that it is characterized in that the Fructus Perillae oil that contains 60-70% weight α-linoleic acid of 99% weight that will extract from the Folium Perillae seed and 1% weight mixes, it is standby in addition the ethyl hydroxybenzoate of the glycerol of the gelatin of 1 part of weight, 0.3 part of weight, 0.0015 part of weight and an amount of distilled water mix homogeneously to be made the storage tank of packing into behind the rubber, and foregoing thing and rubber are made soft gelatin capsule by the drop pill machine.
4. preparation method as claimed in claim 3, the content that it is characterized in that described every capsules is a 250mg weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96116616A CN1184634A (en) | 1996-12-13 | 1996-12-13 | Omega -3 capsule and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96116616A CN1184634A (en) | 1996-12-13 | 1996-12-13 | Omega -3 capsule and method for preparing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1184634A true CN1184634A (en) | 1998-06-17 |
Family
ID=5123709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96116616A Pending CN1184634A (en) | 1996-12-13 | 1996-12-13 | Omega -3 capsule and method for preparing same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1184634A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931232B (en) * | 2006-09-21 | 2011-11-09 | 西北农林科技大学 | Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process |
| CN102934703A (en) * | 2012-11-13 | 2013-02-20 | 中国食品发酵工业研究院 | Flaxseed oil microcapsule and production method thereof |
| CN103082296A (en) * | 2012-12-26 | 2013-05-08 | 东莞市照燕生物科技有限公司 | Dietary supplement for reducing attacking of myocardial infarction |
| CN103596453A (en) * | 2011-05-30 | 2014-02-19 | 林来福医药公司 | Health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil, and method for obtaining the same |
-
1996
- 1996-12-13 CN CN96116616A patent/CN1184634A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931232B (en) * | 2006-09-21 | 2011-11-09 | 西北农林科技大学 | Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process |
| CN103596453A (en) * | 2011-05-30 | 2014-02-19 | 林来福医药公司 | Health-giving foodstuff containing ethyl esters of fatty acids, namely of linen oil, and method for obtaining the same |
| CN102934703A (en) * | 2012-11-13 | 2013-02-20 | 中国食品发酵工业研究院 | Flaxseed oil microcapsule and production method thereof |
| CN102934703B (en) * | 2012-11-13 | 2015-07-15 | 中国食品发酵工业研究院 | Flaxseed oil microcapsule and production method thereof |
| CN103082296A (en) * | 2012-12-26 | 2013-05-08 | 东莞市照燕生物科技有限公司 | Dietary supplement for reducing attacking of myocardial infarction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69935995T2 (en) | POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT | |
| TWI358292B (en) | Composition with effects of decline prevention, im | |
| Alvarez et al. | Lipids in pharmaceutical and cosmetic preparations | |
| AU766660B2 (en) | Utilization of material containing docosapentaenoic acid | |
| DE69013923T2 (en) | MEDICINAL FORMULATIONS. | |
| TWI268761B (en) | Improved methods of incorporating polyunsaturated fatty acids in milk | |
| DE3920679C2 (en) | ||
| JPH044298B2 (en) | ||
| CN108835262A (en) | A kind of modulation milk powder and preparation method thereof improving memory | |
| KR101380652B1 (en) | Enteric coated soft capsule composition containing purified fish oil and its preparation method | |
| US20050014825A1 (en) | Preparation and use of solidified oils | |
| Krámer et al. | The Effect of Different Factors on the Composition of Human Milk and its Variations. III. Effect of Dietary Fats on the Lipid Composition of Human Milk: Wirkung verschiedener Faktoren auf die Zusammensetzung menschlicher Milch. III. Wirkung des Nahrungsfettes auf den Fettgehalt der menschlichen Milch.–Effet de différents facteurs sur la composition du lait humain et ses variations. III. Effet des graisses alimentaires sur la composition en lipides du lait humain | |
| FR2773484A1 (en) | NEW COMPOSITIONS WITH SYNERGISTIC EFFECT BETWEEN MICRONUTRIENTS AND SUBSTANCES OF LIVING ORIGIN | |
| CN1184634A (en) | Omega -3 capsule and method for preparing same | |
| JPH0975000A (en) | Food or drink containing oil and fat for nourishing mother and child | |
| CN113747796B (en) | Method for making monoacylglyceride oils and food products containing monoacylglyceride oils | |
| JP5096658B2 (en) | Soft capsule with improved bioavailability | |
| JPS6115647A (en) | Oil and fat food | |
| JPH11500909A (en) | Infant formula supplement and method of dispensing the supplement | |
| JPH0336493B2 (en) | ||
| JP2017002015A (en) | Supplement and production method thereof | |
| Guilliams | Fatty Acids: Essential… Therapeutic | |
| Lee | Essent ial Fat ty Acids | |
| JPH0371100B2 (en) | ||
| JPS6281310A (en) | Medicinal drink containing gamma-linolenic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |